Importantly, HSP90 overexpression in COPD patients receiving formoterol/corticosteroid therapy correlates with glucocorticoid receptor (GR) dysfunction and impaired transcriptional activity, providing a mechanistic basis for the limited efficacy of inhaled corticosteroids in COPD management.27 This evidence concerns the gene HSP90AA1 and chronic obstructive pulmonary disease.